Vericel Corporation (VCEL)
NASDAQ • Healthcare
Last close at September 4, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Vericel Corporation keeps $3 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 62 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Vericel’s revenue topped consensus and rose year over year in the second fiscal quarter of 2026, reported July 30, 2026, with revenue of $77.5 million against a $72.7 million estimate, +6.5%, and up 22.5% from roughly $63.2 million a year ago. Profitability remained concentrated in gross profit, which came in at about $56.4 million with gross margin near 73%, while operating income was roughly $0.4 million for an operating margin of about 0.6%. Net income was about $2.2 million, improving from roughly negative $0.6 million a year ago, and EPS was $0.04 versus $-0.01 in the prior-year period. The company generated operating cash flow of about $16.2 million. For the next period, consensus calls for EPS of $0.02 on revenue of $78.0 million.
About Vericel Corporation
Vericel Corporation is a NASDAQ-listed healthcare company focused on biotechnology-based cell therapies. It researches, develops, produces, and distributes treatments for sports medicine and critical burn care in the United States, where it generated $276.3 million of revenue in FY2025 from its marketed burn-care and cartilage-repair portfolio.
Today's Snapshot
VCEL closed 0.7% below yesterday's close, in line with a weaker sector. Trading was lighter than usual, with volume about two-thirds of its usual level.
Trading Volume
Below 10d avg (491.4K)
312.9K
vs S&P 500 Today
Moderate Underperformance
-0.27%
Updated: September 4, 2026 at 20:21 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$39.12 - $42.62Sell
- RSI (14)35.63Neutral
- Stochastic %K (14, 3, 3)17.64Buy
- MACD Level (12, 26)-1.15Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.